Slate Path Capital LP - Q3 2017 holdings

$1.9 Billion is the total value of Slate Path Capital LP's 23 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 68.8% .

 Value Shares↓ Weighting
TWTR BuyTWITTER INC$261,232,000
-3.4%
15,485,000
+2.3%
13.74%
+33.7%
CHTR  CHARTER COMMUNICATIONS INC Ncl a$219,869,000
+7.9%
605,0000.0%11.56%
+49.4%
ALLY SellALLY FINL INC$188,743,000
-14.6%
7,780,000
-26.5%
9.93%
+18.2%
TIF BuyTIFFANY & CO NEW$161,074,000
+13.3%
1,755,000
+15.8%
8.47%
+56.8%
PODD SellINSULET CORP$149,818,000
+4.5%
2,720,000
-2.7%
7.88%
+44.6%
AAP BuyADVANCE AUTO PARTS INC$148,304,000
+21.7%
1,495,000
+43.1%
7.80%
+68.6%
CAR BuyAVIS BUDGET GROUP$129,785,000
+53.5%
3,410,000
+10.0%
6.83%
+112.6%
DXC BuyDXC TECHNOLOGY CO$97,474,000
+45.2%
1,135,000
+29.7%
5.13%
+101.0%
TRIP NewTRIPADVISOR INC$83,694,0002,065,000
+100.0%
4.40%
P BuyPANDORA MEDIA INC$79,156,000
+61.2%
10,280,000
+86.7%
4.16%
+123.2%
LYV NewLIVE NATION ENTERTAINMENT IN$68,591,0001,575,000
+100.0%
3.61%
ALNY SellALNYLAM PHARMACEUTICALS INC$65,912,000
-27.2%
561,000
-50.6%
3.47%
+0.8%
CF NewCF INDS HLDGS INC$60,827,0001,730,000
+100.0%
3.20%
X NewUNITED STATES STL CORP NEW$57,222,0002,230,000
+100.0%
3.01%
SPY SellSPDR S&P 500 ETF TRcall$53,386,000
-87.4%
212,500
-87.9%
2.81%
-82.5%
MDCO BuyMEDICINES CO$41,114,000
+98.5%
1,110,000
+103.7%
2.16%
+174.7%
GDX SellVANECK VECTORS ETF TRgold miners etf$8,679,000
-93.4%
378,000
-93.6%
0.46%
-90.8%
SIL NewGLOBAL X FDSglobal x silver$7,390,000224,000
+100.0%
0.39%
LULU NewLULULEMON ATHLETICA INC$5,354,00086,000
+100.0%
0.28%
DXCM NewDEXCOM INC$4,550,00093,000
+100.0%
0.24%
SSW  SEASPAN CORP$3,191,000
-0.7%
450,0000.0%0.17%
+37.7%
HTZGQ NewHERTZ GLOBAL HLDGS INC$3,108,000139,000
+100.0%
0.16%
IPXL NewIMPAX LABORATORIES INC$2,944,000145,000
+100.0%
0.16%
TSO ExitTESORO CORP$0-1,180,000
-100.0%
-4.20%
QQQ ExitPOWERSHARES QQQ TRUSTcall$0-4,000,000
-100.0%
-20.91%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13
SC 13G2022-11-18

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings